Cerus (CERS) Enterprise Value Growth (1y) (2011 - 2026)
Cerus (CERS) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.59% |
| Dec 31, 2025 | -3.06% |
| Sep 30, 2025 | -4.01% |
| Jun 30, 2025 | -9.77% |
| Mar 31, 2025 | -12.30% |
| Dec 31, 2024 | -22.51% |
| Sep 30, 2024 | 4.32% |
| Jun 30, 2024 | 15.82% |
| Mar 31, 2024 | 23.85% |
| Dec 31, 2023 | 35.71% |
| Sep 30, 2023 | 24.03% |
| Jun 30, 2023 | 21.15% |
| Mar 31, 2023 | 12.84% |
| Dec 31, 2022 | 21.16% |
| Sep 30, 2022 | 13.52% |
| Jun 30, 2022 | 13.66% |
| Mar 31, 2022 | 18.35% |
| Dec 31, 2021 | 3.92% |
| Sep 30, 2021 | 11.96% |
| Mar 31, 2021 | 1.04% |